Pharmacologic therapy for inflammatory bowel disease refractory to steroids. [revisión]
Por: Martínez Montiel, Pilar [Aparato Digestivo]
| Casís Herce, Begoña [Aparato Digestivo] | Gómez Gómez, Gonzalo Jesús [Aparato Digestivo] | Masedo González, Ángeles [Aparato Digestivo] | Yela San Bernardino, Carmen [Aparato Digestivo] | Piedracoba Cadahia, Carlos [Aparato Digestivo] | Castellano Tortajada, Gregorio [Aparato Digestivo].
Colaborador(es): Servicio de Medicina del Aparato Digestivo.
Tipo de material: 
ArtículoEditor: Clinical and experimental gastroenterology, 2015Descripción: 8:257-69.Recursos en línea: Acceso libre Resumen: Although corticosteroids are an effective treatment for induction of remission in inflammatory bowel disease (IBD), many patients are dependent on or refractory to corticosteroids. This review is based on scrutinizing current literature with emphasis on randomized controlled trials, meta-analyses, and Cochrane reviews on the management of IBD refractory to corticosteroids. Based on this evidence, we propose algorithms and optimization strategies for use of immunomodulator and biologic therapy in IBD refractory to corticosteroids.
| Tipo de ítem | Ubicación actual | Signatura | Estado | Fecha de vencimiento |
|---|---|---|---|---|
Revisión
|
PC17234 (Navegar estantería) | Disponible |
Formato Vancouver:
Martínez Montiel MP, Casis Herce B, Gómez Gómez GJ, Masedo González A, Yela San Bernardino C, Piedracoba C et al. Pharmacologic therapy for inflammatory bowel disease refractory to steroids. Clin Exp Gastroenterol. 2015 Aug 17;8:257-69.
PMID: 26316792
PMC4544729
Contiene 87 referencias
Although corticosteroids are an effective treatment for induction of remission in inflammatory bowel disease (IBD), many patients are dependent on or refractory to corticosteroids. This review is based on scrutinizing current literature with emphasis on randomized controlled trials, meta-analyses, and Cochrane reviews on the management of IBD refractory to corticosteroids. Based on this evidence, we propose algorithms and optimization strategies for use of immunomodulator and biologic therapy in IBD refractory to corticosteroids.
No hay comentarios para este ejemplar.